Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis.

Bertholet-Thomas A, Guittet C, Manso-Silván MA, Joukoff S, Navas-Serrano V, Baudouin V, Cailliez M, Di Maio M, Gillion-Boyer O, Golubovic E, Harambat J, Knebelmann B, Nobili F, Novo R, Podracka L, Roussey-Kesler G, Granier LA.

Open source

DOI
10.1007/s00467-020-04873-0
Published
2021-02-26
Container
Pediatr Nephrol
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00467-020-04873-0,
  title = {Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis.},
  author = {Bertholet-Thomas A and  Guittet C and  Manso-Silván MA and  Joukoff S and  Navas-Serrano V and  Baudouin V and  Cailliez M and  Di Maio M and  Gillion-Boyer O and  Golubovic E and  Harambat J and  Knebelmann B and  Nobili F and  Novo R and  Podracka L and  Roussey-Kesler G and  Granier LA.},
  year = {2021},
  journal = {Pediatr Nephrol},
  doi = {10.1007/s00467-020-04873-0},
  url = {https://doi.org/10.1007/s00467-020-04873-0}
}

RIS

TY  - JOUR
TI  - Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis.
AU  - Bertholet-Thomas A
AU  -  Guittet C
AU  -  Manso-Silván MA
AU  -  Joukoff S
AU  -  Navas-Serrano V
AU  -  Baudouin V
AU  -  Cailliez M
AU  -  Di Maio M
AU  -  Gillion-Boyer O
AU  -  Golubovic E
AU  -  Harambat J
AU  -  Knebelmann B
AU  -  Nobili F
AU  -  Novo R
AU  -  Podracka L
AU  -  Roussey-Kesler G
AU  -  Granier LA.
PY  - 2021
JO  - Pediatr Nephrol
DO  - 10.1007/s00467-020-04873-0
UR  - https://doi.org/10.1007/s00467-020-04873-0
ER  - 

APA

A, B., C, G., MA, M., S, J., V, N., V, B., M, C., M, D. M., O, G., E, G., J, H., B, K., F, N., R, N., L, P., G, R., & LA., G. (2021). Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis.. Pediatr Nephrol. https://doi.org/10.1007/s00467-020-04873-0

Source records